Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

بواسطة Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., de Haard, Hans, Leupin, Nicolas, Kuter, David J.
الحاوية / القاعدة Am J Hematol (2019)

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

بواسطة Howard, James F., Bril, Vera, Burns, Ted M., Mantegazza, Renato, Bilinska, Malgorzata, Szczudlik, Andrzej, Beydoun, Said, Garrido, Francisco Javier Rodriguez De Rivera, Piehl, Fredrik, Rottoli, Mariarosa, Van Damme, Philip, Vu, Tuan, Evoli, Amelia, Freimer, Miriam, Mozaffar, Tahseen, Ward, E. Sally, Dreier, Torsten, Ulrichts, Peter, Verschueren, Katrien, Guglietta, Antonio, de Haard, Hans, Leupin, Nicolas, Verschuuren, Jan J.G.M.
الحاوية / القاعدة Neurology (2019)